I think it is worth taking a look at how CU6 has managed to avoid being taken out despite all the other radiotheranostic companies at a similar stage of development being taken over. For better or worse, Australia appears to be too far away for hostile takeovers in our biotech sector.
I have said this many times before, but the only person who needs to worry about a sale of RAC is me as everyone else can sell out on market if they wish. As long as RAC keeps delivering on its promise then we should see continued demand for RAC shares and with that a SP rise (all things being equal).
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.18 |
Change
0.010(0.86%) |
Mkt cap ! $204.1M | |||
| Open | High | Low | Value | Volume |
| $1.19 | $1.19 | $1.17 | $19.63K | 16.71K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 810 | $1.18 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.20 | 2188 | 1 |
View Market Depth
| Last trade - 15.52pm 11/07/2025 (20 minute delay) ? |
| RAC (ASX) Chart |